APOE genotype is a major predictor of long-term progression of disability in MS -: Reply from the authors

被引：0
|
作者：
Chapman, J
Korezyn, AD
Michaelson, DM
机构：
来源：
NEUROLOGY | 2001年 / 57卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：2148 / 2149
页数：2
相关论文
共 50 条
  • [21] A propensity-matched comparison of long-term disability progression in ms patients treated with dimethyl fumarate or fingolimod
    Fox, R.
    Lancia, S.
    Cutter, G.
    Marrie, R. -A.
    Mendoza, J.
    Lewin, J.
    Salter, A.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 128 - 128
  • [22] Validation of a clinical risk score for long-term progression of MS
    Aurencao, J. C. K.
    Vasconcelos, C. C. F.
    Thuler, L. C. S.
    Alvarenga, R. M. P.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 740 - 740
  • [23] Pregnancy in women with MS - impact on long-term disability in a Danish cohort
    Andersen, J. B.
    Andersen, P. K.
    Sellebjerg, F.
    Magyari, M.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 244 - 245
  • [24] Relapse recovery in ms: effect of treatment and contribution to long-term disability
    Sotiropoulos, M.
    Lokhande, H.
    Healy, B.
    Polgar-Turcsanyi, M.
    Glanz, B.
    Bakshi, R.
    Weiner, H.
    Chitnis, T.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 351 - 351
  • [25] Progression to disability milestones in multiple sclerosis with long-term natalizumab treatment
    Trojano, Maria
    Butzkueven, Helmut
    Kappos, Ludwig
    Wiendl, Heinz
    Spelman, Tim
    Pellegrini, Fabio
    Pellegrini, Fabio
    Dong, Qunming
    Kondgen, Harold
    Belachew, Shibeshih
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : NP2 - NP2
  • [26] Long-Term Natalizumab Therapy: Progression of Disability and EDSS Milestones.
    Butzkueven, H.
    Trojano, M.
    Kappos, L.
    Wiendl, H.
    Spelman, T.
    Pellegrini, F.
    Chen, Y.
    Dong, Q.
    Koendgen, H.
    Belachew, S.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (03) : 419 - 419
  • [27] Progression to disability milestones in multiple sclerosis with long-term natalizumab treatment
    Trojano, M.
    Butzkueven, H.
    Kappos, L.
    Wiendl, H.
    Spelman, T.
    Pellegrini, F.
    Chen, Y.
    Dong, Q.
    Koendgen, H.
    Belachew, S.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 562 - 563
  • [28] Long-term disability progression of pediatric-onset multiple sclerosis
    Mckay, Kyla A.
    Hillert, Jan
    Manouchehrinia, Ali
    NEUROLOGY, 2019, 92 (24) : E2764 - E2773
  • [29] Long-term disability progression of paediatric-onset multiple sclerosis
    McKay, K. A.
    Hillert, J.
    Manouchehrinia, A.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 544 - 544
  • [30] Smoking as a predictor of long-term work disability in physically active and inactive people
    Eriksen, W
    Natvig, B
    Rutle, O
    Bruusgaard, D
    OCCUPATIONAL MEDICINE-OXFORD, 1998, 48 (05): : 315 - 320
12345